profit from every €100 of sales.
€0€100
Clariane
€3.40-2.07% today
-11.6% since Dec 23, 25
1-year low €3.111-year high €4.35
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €761.61 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Clariane sold, what it kept, and what it did with the cash.
Sales went from €4.44 billion in 2022 to €5.31 billion in 2025, with €1.60 million of profit last year.
SalesProfit
Clariane handed back 9% of the cash it generated last year.
€70M
Free cash flow 2025€816M
Bought back its own shares–
Paid as dividends€70M
Cash vs. debt€785M vs. €7.8B
Clariane vs. similar companies
Clariane grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Clariane | 761.6× · Very expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads Clariane's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4,438 | 4,996 | 5,282 | 5,310 | |
| 4,086 | 4,592 | 4,843 | 4,891 | |
| 334 | 317 | 287 | 284 | |
| 909 | 952 | 1,060 | 1,153 | |
| 22 | -105 | -55 | 2 | |
| 0.08 | -0.62 | -0.24 | – | |
| 92.1% | 91.9% | 91.7% | 92.1% | |
| 7.5% | 6.3% | 5.4% | 5.3% | |
| 0.5% | -2.1% | -1.0% | 0.0% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 14,574 | 15,181 | 14,261 | 13,807 |
| Cash | 734 | 678 | 518 | 785 |
| Total debt | 8,271 | 8,555 | 7,981 | 7,807 |
| Total liabilities | 10,706 | 11,243 | 10,240 | 9,905 |
| 3,539 | 3,584 | 3,692 | 3,614 | |
| 193 | 171 | 231 | – | |
| 1.6% | 1.2% | 1.9% | 2.1% | |
| 0.6% | -2.9% | -1.5% | 0.0% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 862 | 793 | 908 | 1,072 | |
| 622 | 484 | 308 | 256 | |
| 240 | 309 | 600 | 816 | |
| Dividends paid | 58 | 66 | 51 | 70 |
| 6 | 0 | – | – | |
| – | – | – | – |
Valuation
- 761.6×
- –
- –
- 0.4×
- 0.2×
- 1.5×
- 7.1×
- 67.2%
- 0.1%
- 5.8%
Profitability
- 92.1%
- 5.3%
- 0.0%
- –
- 2.1%
- 1.7%
- –
- –
- –
- –
Growth
- +6.2%
- –
- –
- –
- +5.7%
Financial health
- 6.1×
- 2.16
- –
- 1.0×
- 0.71
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 42%of 946
Bottom 40%of 871
Bottom 31%of 867
Top 1%of 986
5.8%of the share price, paid each year
On $1,000 invested$58a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
4,386.0% of its profit
Room to growStretchedMore than it earns: 8.6%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
24No pass
Benjamin Graham
43No pass
Philip Fisher
28No pass
Peter Lynch
26No pass
Joel Greenblatt
8No pass
Charlie Munger
16No pass
Terry Smith
26No pass
Questions about Clariane
Is Clariane a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Clariane AI analysis
What does Clariane do?
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. It is in Medical Care Facilities, based in Paris, France, with 70,685 employees.
Does Clariane pay a dividend?
Yes. At today's price the dividend is 5.8% a year. In 2025 it paid out €70.0 million in dividends.
Is Clariane stock halal?
No. Clariane does not pass our halal screen: its debt is 643% of its market value, at or above the 33% limit. How we check
Who are Clariane's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Clariane's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.